Javascript must be enabled to continue!
Quantitative evaluation of cardiopulmonary functional reserve in pulmonary embolism patients after treatment
View through CrossRef
Background
There is no research focusing on assessing cardiopulmonary functional reserve and exercise tolerance in patients with pulmonary embolism (PE) both at home and abroad, but the benefits of early exercise are well recognised. The goal of this study was to assess cardiopulmonary functional reserve in patients with PE by using the inert gas rebreathing method of cardiopulmonary exercise test (CPET), and compare with the traditional methods.
Methods
CPET on the bicycle ergometer were performed in 40 patients with age, gender, body mass index (BMI), systolic blood pressure, and pulmonary function matched. The first group was PE group composed of 16 PE patients (5 male, 11 female) who were given the standard antithrombotic therapy for 2 weeks. The other group was composed of 24 normal individuals (10 male, 14 female). Both the two groups were evaluated by cardiac ultrasound examination, 6 min walking test (6MWT), and CPET.
Results
(1) Right ventricular systolic pressure (RVSP) of PE group increased significantly than the control group ((34.81±8.15) mm Hg to (19.75±3.47) mm Hg, p<0.01). But neither right atrial end-systolic diameter (RASD) nor right ventricular end-diastolic diameter (RVDD) of PE patients had changed compared with controls (RASD: (38.19±3.70) mm to (36.69±3.20) mm, p>0.05; RVDD: (32.75±4.19) mm to (31.06±4.12) mm, p>0.05). 6 min walk distance was significantly reduced in patients with PE compared with normal subjects ((447.81±79.20) m to (513.75±31.45) m, p<0.01). Both VO2 AT and VO2 peak were significantly decreased in patients with PE compared with controls (VO2AT: (9.44±3.82) ml/kg/min to (14.62±2.93) ml/kg/min, p<0.01; VO2 peak: (12.26±4.06) ml/kg/min to (23.46±6.15) ml/kg/min, p<0.01). VE/VCO2 slope was increased in patients with PE ((35.47±6.66) to (26.94±3.16), p<0.01). There was no significant descend in resting cardiac output (CO) between PE and normal group ((4.03±1.80) l/min to (4.59±1.34) l/min, p>0.05), while peak cardiac output (peak CO) and the difference between exercise and resting cardiac output (CO) were both significantly reduced in patients with PE (peak CO: (5.97±2.25) l/min to (8.50±3.13) l/min, p<0.01; CO: (1.29±1.59) l/min to (3.97±2.02) l/min, p<0.01). (2) 6 min walk distance didn't correlated with CPET except VO2 peak (r=0.675, p<0.01).
Conclusions
Cardiopulmonary functional reserve was reduced in patients with PE in our study. CPET is an accurate, quantitative evaluation of cardiopulmonary functional reserve in patients with PE.
Title: Quantitative evaluation of cardiopulmonary functional reserve in pulmonary embolism patients after treatment
Description:
Background
There is no research focusing on assessing cardiopulmonary functional reserve and exercise tolerance in patients with pulmonary embolism (PE) both at home and abroad, but the benefits of early exercise are well recognised.
The goal of this study was to assess cardiopulmonary functional reserve in patients with PE by using the inert gas rebreathing method of cardiopulmonary exercise test (CPET), and compare with the traditional methods.
Methods
CPET on the bicycle ergometer were performed in 40 patients with age, gender, body mass index (BMI), systolic blood pressure, and pulmonary function matched.
The first group was PE group composed of 16 PE patients (5 male, 11 female) who were given the standard antithrombotic therapy for 2 weeks.
The other group was composed of 24 normal individuals (10 male, 14 female).
Both the two groups were evaluated by cardiac ultrasound examination, 6 min walking test (6MWT), and CPET.
Results
(1) Right ventricular systolic pressure (RVSP) of PE group increased significantly than the control group ((34.
81±8.
15) mm Hg to (19.
75±3.
47) mm Hg, p<0.
01).
But neither right atrial end-systolic diameter (RASD) nor right ventricular end-diastolic diameter (RVDD) of PE patients had changed compared with controls (RASD: (38.
19±3.
70) mm to (36.
69±3.
20) mm, p>0.
05; RVDD: (32.
75±4.
19) mm to (31.
06±4.
12) mm, p>0.
05).
6 min walk distance was significantly reduced in patients with PE compared with normal subjects ((447.
81±79.
20) m to (513.
75±31.
45) m, p<0.
01).
Both VO2 AT and VO2 peak were significantly decreased in patients with PE compared with controls (VO2AT: (9.
44±3.
82) ml/kg/min to (14.
62±2.
93) ml/kg/min, p<0.
01; VO2 peak: (12.
26±4.
06) ml/kg/min to (23.
46±6.
15) ml/kg/min, p<0.
01).
VE/VCO2 slope was increased in patients with PE ((35.
47±6.
66) to (26.
94±3.
16), p<0.
01).
There was no significant descend in resting cardiac output (CO) between PE and normal group ((4.
03±1.
80) l/min to (4.
59±1.
34) l/min, p>0.
05), while peak cardiac output (peak CO) and the difference between exercise and resting cardiac output (CO) were both significantly reduced in patients with PE (peak CO: (5.
97±2.
25) l/min to (8.
50±3.
13) l/min, p<0.
01; CO: (1.
29±1.
59) l/min to (3.
97±2.
02) l/min, p<0.
01).
(2) 6 min walk distance didn't correlated with CPET except VO2 peak (r=0.
675, p<0.
01).
Conclusions
Cardiopulmonary functional reserve was reduced in patients with PE in our study.
CPET is an accurate, quantitative evaluation of cardiopulmonary functional reserve in patients with PE.
Related Results
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Abstract
Introduction
In patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protectiv...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Is Clomiphene the Culprit?
Is Clomiphene the Culprit?
Pulmonary embolism is a well known culprit in the medical world with a mortality as high as 30% for untreated population [1]. Multiple risk factors have been described including, b...
Being Immobilized Involves A High Risk of Pulmonary Embolism
Being Immobilized Involves A High Risk of Pulmonary Embolism
Abstract
Introduction:
The clinical symptoms of pulmonary embolism are diverse and in some patients, pulmonary
embolism can be easily overlooked and cause serious clinical conseque...
Multislice computed tomography angiography in assessment of pulmonary vascular abnormalities
Multislice computed tomography angiography in assessment of pulmonary vascular abnormalities
Abstract
Background
Multidetector computed tomography (CT) angiography with maximum intensity projection, multiplanar reformations and 3D reconst...
THE RETROGRADE LEFT ATRIAL TUMOUR EMBOLISM IN THE PATIENT WITH METASTATIC EXTREMITY CHONDROSARCOMA
THE RETROGRADE LEFT ATRIAL TUMOUR EMBOLISM IN THE PATIENT WITH METASTATIC EXTREMITY CHONDROSARCOMA
The malignancy-related coagulation and secondary pulmonary embolism are common in sarcomas, whereas tumour embolism and pulmonary venous embolism are extremely rare. It is crucial ...

